Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

In our DNA: Silvio Cenzi, Senior Manager, Field Service Field Support

September 14, 2022

We’re continuing our blog series, looking at the DNA of Telesis Bio — our incredible employees and their stories.

Team member: Silvio Cenzi, Senior Manager, Field Service Field Support
Came aboard: January 10, 2022

What do you do at Telesis Bio?
I lead a team of field service engineers globally. We support the daily needs of our customers.

How did you get into that kind of work?
I love science, and I’m passionate about teaching and troubleshooting technologies. I have always enjoyed being in a position where I can help others with troubleshooting. It’s quite rewarding to know that while I am supporting our customers, I am also contributing to bringing science a step closer to resolving some of the world’s most challenging problems.

How would you describe the company culture?
The Telesis Bio people are the most important part of what defines our company culture. The benefit of working for a smaller company is that everyone is very supportive and committed, and our CEO and VPs are accessible.

How would you describe synthetic biology to non-scientists?
I would compare it to a Swiss Army Knife. It’s a breakthrough technology that can speed up innovation in drug development, agriculture, and solving environmental challenges. Having synthetic biology at your fingertips is like switching from physical letters to emails to communicate; it allows genetic engineering to bypass tedious steps in the process.

What’s something fun about working at Telesis Bio?
There is a sense of community and support. We have team-building activities, BBQs, and happy hour events.

What was the first thing you ever wanted to be when you grew up?
I wanted to be a fighter pilot.

How do you see synthetic biology changing the world?
Imagine a world where food can grow in harsh environments, where designer microorganisms decompose plastic waste. Also, imagine doctors being able to engineer antibodies that would target only cancer cells without the side effects and curing rare and new diseases that have been falling through the cracks because of the high cost.

Share via
Copy link
Powered by Social Snap